SpaceX is reportedly laying off about 10% of its workforce
- SpaceX, the rocket company owned by Elon Musk, will lay off about 10% of its employees, the Los Angeles Times reported on Friday citing an unnamed source.
- The company has more than 6,000 employees and has been working rapidly to build and start testing a prototype of its brand-new rocket system.
Here's the statement SpaceX gave to the LA Times:
"To continue delivering for our customers and to succeed in developing interplanetary spacecraft and a global space-based Internet, SpaceX must become a leaner company. Either of these developments, even when attempted separately, have bankrupted other organizations. This means we must part ways with some talented and hardworking members of our team."According to the LA Times, SpaceX is offering the affected employees eight weeks' severance pay and other career resources.
The news was reportedly sent to SpaceX employees in an email from company president and COO Gwynne Shotwell.The layoffs come less than a month after SpaceX announced plans to raise another $500 million in investment funding. The company had previously raised $507 million April 2018. That money is likely being used to further two ambitious projects. The company is trying to develop, build, and launch Starlink, an effort to cover Earth in ultra-fast broadband internet. It's also building the prototype of its Big Falcon Rocket system (BFR), which is designed to bring people to Mars.Advertisement
SpaceX also hopes to use BFR to send a Japanese billionaire and a crew of artists around the moon and create the world's fastest transportation system.
- On World Tourism Day, India’s Oil Minister asks prime tourist cities in the country to completely switch to clean fuels
- President Ram Nath Kovind approves all three farm bills which have been the reason for farmers' protests across the country
- Four Delhi cops face heat for misreporting drug seizure
- Former union minister Jaswant Singh passes away at 82
- Odisha man arrested for manufacturing fake Covid-19 vaccine